CRISPR screening in patient-derived intestinal organoids for inflammatory bowel disease target discovery at the FGSL - Antigoni Gogolou
ELRIG Drug Discovery 2026 · 14 October 2026 · 14:40–15:10 · Tech Theatre
CRISPR screening in patient-derived intestinal organoids for inflammatory bowel disease target discovery at the FGSL - Antigoni Gogolou was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 1 speaker on record.
Speakers
- Antigoni Gogolou — Speaker Research Associate, Milner Therapeutics Institute, University Of Cambridge